Daniela Catarzi has held the position of Assistant Professor of Medicinal Chemistry at the University of Florence since 1998. She received her degree in Pharmaceutical Chemistry and Technology in 1990 and her PhD in Medicinal Chemistry in 1993. Her early research focused on the identification of benzodiazepine receptor ligands and GABAA receptor antagonists. In recent years, her attention has been directed toward the development of adenosine receptor ligands, carbonic anhydrase modulators, and kinase and CD73 inhibitors, which represent possible new therapeutical strategies for the treatment of neurodegenerative diseases and cancer.
Daniela Catarzi has held the position of Assistant Professor of Medicinal Chemistry at the University of Florence since 1998. She received her degree in Pharmaceutical Chemistry and Technology in 1990 and her PhD in Medicinal Chemistry in 1993. Her early research focused on the identification of benzodiazepine receptor ligands and GABAA receptor antagonists. In recent years, her attention has been directed toward the development of adenosine receptor ligands, carbonic anhydrase modulators, and kinase and CD73 inhibitors, which represent possible new therapeutical strategies for the treatment of neurodegenerative diseases and cancer.